167 related articles for article (PubMed ID: 22464928)
1. Radiolabeling of DOTATOC with the long-lived positron emitter 44Sc.
Pruszyński M; Majkowska-Pilip A; Loktionova NS; Eppard E; Roesch F
Appl Radiat Isot; 2012 Jun; 70(6):974-9. PubMed ID: 22464928
[TBL] [Abstract][Full Text] [Related]
2. Optimization of reaction conditions for the radiolabeling of DOTA and DOTA-peptide with (44m/44)Sc and experimental evidence of the feasibility of an in vivo PET generator.
Huclier-Markai S; Kerdjoudj R; Alliot C; Bonraisin AC; Michel N; Haddad F; Barbet J
Nucl Med Biol; 2014 May; 41 Suppl():e36-43. PubMed ID: 24361353
[TBL] [Abstract][Full Text] [Related]
3. Post-elution processing of (44)Ti/(44)Sc generator-derived (44)Sc for clinical application.
Pruszyński M; Loktionova NS; Filosofov DV; Rösch F
Appl Radiat Isot; 2010 Sep; 68(9):1636-41. PubMed ID: 20434351
[TBL] [Abstract][Full Text] [Related]
4. Promises of cyclotron-produced 44Sc as a diagnostic match for trivalent β--emitters: in vitro and in vivo study of a 44Sc-DOTA-folate conjugate.
Müller C; Bunka M; Reber J; Fischer C; Zhernosekov K; Türler A; Schibli R
J Nucl Med; 2013 Dec; 54(12):2168-74. PubMed ID: 24198390
[TBL] [Abstract][Full Text] [Related]
5. Processing of generator-produced 68Ga for medical application.
Zhernosekov KP; Filosofov DV; Baum RP; Aschoff P; Bihl H; Razbash AA; Jahn M; Jennewein M; Rösch F
J Nucl Med; 2007 Oct; 48(10):1741-8. PubMed ID: 17873136
[TBL] [Abstract][Full Text] [Related]
6. Validation of (68)Ge/(68)Ga generator processing by chemical purification for routine clinical application of (68)Ga-DOTATOC.
Asti M; De Pietri G; Fraternali A; Grassi E; Sghedoni R; Fioroni F; Roesch F; Versari A; Salvo D
Nucl Med Biol; 2008 Aug; 35(6):721-4. PubMed ID: 18678358
[TBL] [Abstract][Full Text] [Related]
7. Separation of
Larenkov AA; Makichyan AG; Iatsenko VN
Molecules; 2021 Oct; 26(21):. PubMed ID: 34770780
[TBL] [Abstract][Full Text] [Related]
8. Bone metastases in patients with neuroendocrine tumor: 68Ga-DOTA-Tyr3-octreotide PET in comparison to CT and bone scintigraphy.
Putzer D; Gabriel M; Henninger B; Kendler D; Uprimny C; Dobrozemsky G; Decristoforo C; Bale RJ; Jaschke W; Virgolini IJ
J Nucl Med; 2009 Aug; 50(8):1214-21. PubMed ID: 19617343
[TBL] [Abstract][Full Text] [Related]
9. Cyclotron production of high purity (44m,44)Sc with deuterons from (44)CaCO3 targets.
Alliot C; Kerdjoudj R; Michel N; Haddad F; Huclier-Markai S
Nucl Med Biol; 2015 Jun; 42(6):524-9. PubMed ID: 25794463
[TBL] [Abstract][Full Text] [Related]
10. Scandium-44: benefits of a long-lived PET radionuclide available from the (44)Ti/(44)Sc generator system.
Roesch F
Curr Radiopharm; 2012 Jul; 5(3):187-201. PubMed ID: 22642388
[TBL] [Abstract][Full Text] [Related]
11. Microwave-supported preparation of (68)Ga bioconjugates with high specific radioactivity.
Velikyan I; Beyer GJ; Långström B
Bioconjug Chem; 2004; 15(3):554-60. PubMed ID: 15149183
[TBL] [Abstract][Full Text] [Related]
12. Macrocyclic complexes of scandium radionuclides as precursors for diagnostic and therapeutic radiopharmaceuticals.
Majkowska-Pilip A; Bilewicz A
J Inorg Biochem; 2011 Feb; 105(2):313-20. PubMed ID: 21194633
[TBL] [Abstract][Full Text] [Related]
13. Desferrioxamine as an appropriate chelator for 90Nb: comparison of its complexation properties for M-Df-Octreotide (M = Nb, Fe, Ga, Zr).
Radchenko V; Busse S; Roesch F
Nucl Med Biol; 2014 Oct; 41(9):721-7. PubMed ID: 25087170
[TBL] [Abstract][Full Text] [Related]
14. Radiolabelling DOTA-peptides with 68Ga.
Breeman WA; de Jong M; de Blois E; Bernard BF; Konijnenberg M; Krenning EP
Eur J Nucl Med Mol Imaging; 2005 Apr; 32(4):478-85. PubMed ID: 15655678
[TBL] [Abstract][Full Text] [Related]
15. Impact of Multiphase 68Ga-DOTATOC-PET/CT on therapy management in patients with neuroendocrine tumors.
Ruf J; Heuck F; Schiefer J; Denecke T; Elgeti F; Pascher A; Pavel M; Stelter L; Kropf S; Wiedenmann B; Amthauer H
Neuroendocrinology; 2010; 91(1):101-9. PubMed ID: 19996582
[TBL] [Abstract][Full Text] [Related]
16. A fully automated synthesis for the preparation of 68Ga-labelled peptides.
Decristoforo C; Knopp R; von Guggenberg E; Rupprich M; Dreger T; Hess A; Virgolini I; Haubner R
Nucl Med Commun; 2007 Nov; 28(11):870-5. PubMed ID: 17901771
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of reaction conditions for the radiolabelling of DOTA-peptides with high activities of yttrium-90.
Nardelli A; Castaldi E; Ortosecco G; Speranza A; Storto G; Pace L; Salvatore M
Appl Radiat Isot; 2011 Jan; 69(1):52-5. PubMed ID: 20869877
[TBL] [Abstract][Full Text] [Related]
18. From octreotide to shorter analogues: Synthesis, radiolabeling, stability.
Yakusheva A; Titchenko N; Egorova B; Matazova E; Podkhalyuzina N; Osipov V; Khachatryan D; Avdeev D; Posypanova G; Kalmykov S
J Labelled Comp Radiopharm; 2019 Sep; 62(11):718-728. PubMed ID: 31410877
[TBL] [Abstract][Full Text] [Related]
19. 1-[3-(2-[18F]fluoropyridin-3-yloxy)propyl]pyrrole-2,5-dione: design, synthesis, and radiosynthesis of a new [18F]fluoropyridine-based maleimide reagent for the labeling of peptides and proteins.
de Bruin B; Kuhnast B; Hinnen F; Yaouancq L; Amessou M; Johannes L; Samson A; Boisgard R; Tavitian B; Dollé F
Bioconjug Chem; 2005; 16(2):406-20. PubMed ID: 15769096
[TBL] [Abstract][Full Text] [Related]
20. First-in-Human PET/CT Imaging of Metastatic Neuroendocrine Neoplasms with Cyclotron-Produced
Singh A; van der Meulen NP; Müller C; Klette I; Kulkarni HR; Türler A; Schibli R; Baum RP
Cancer Biother Radiopharm; 2017 May; 32(4):124-132. PubMed ID: 28514206
[No Abstract] [Full Text] [Related]
[Next] [New Search]
